CTSB and cancer: By combining the antitumor activity of chemotherapeutic drugs and the tumor selectivity of antibodies, ADCs display a wider window for cancer chemotherapy than chemotherapeutic drugs alone.[2a] ADCs with cathepsin B‐cleavable linkers are particularly effective, having high plasma stability.